Dextromethorphan reduces sign-tracking but not goal-tracking in male Sprague-Dawley rats

Neurobiol Learn Mem. 2022 Jul:192:107635. doi: 10.1016/j.nlm.2022.107635. Epub 2022 May 18.

Abstract

Sign-tracking is a well-known phenomenon in appetitive Pavlovian conditioning in which subjects approach the site of a conditioned stimulus (CS) associated with an appetitive unconditioned stimulus (US) even when the two are located separately. Control of sign-tracking may be important in rehabilitation from drug dependence to help ward off relapse. Recent studies have found success in using ketamine to reduce sign-tracking. In this study, we employed a similar but unscheduled drug, dextromethorphan (DXM), which affects many of the same molecular targets as ketamine, in an attempt to reduce sign-tracking in a standard paradigm. DXM was found to reduce sign-tracking at the doses examined in this study, while goal-tracking (approaching the site of the US rather than CS) was relatively unaffected. DXM offers advantages over ketamine in terms of use with patients and may have some utility in rehabilitation.

Keywords: Addiction; Dextromethorphan; Goal-tracking; Incentive salience; Pavlovian conditioning; Sign-tracking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cues
  • Dextromethorphan*
  • Humans
  • Ketamine* / pharmacology
  • Male
  • Motivation
  • Rats
  • Rats, Sprague-Dawley
  • Reward

Substances

  • Ketamine
  • Dextromethorphan